WENDY OLD: Open Payments
NPI 1164647699 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 11 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $585 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 2 | $245 |
| KYOWA KIRIN, INC. | 1 | $125 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $113 |
| Novo Nordisk Inc | 1 | $103 |
| ABBVIE INC. | 1 | $99 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $88 |
| Janssen Pharmaceuticals, Inc | 1 | $46 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Leqembi, RECORLEV, WAINUA, VRAYLAR, JOURNAVX, SPRAVATO, AREXVY.
Industry payments across VA — which companies pay providers there.
